Friendly takeover offer for Patheon values contract drug maker at US$1.4 billion + MORE Nov 19th

TSX getting you down? There are always sound investment alternatives.
Latest News

Consumer group that battles the big telcos blames CRTC for its 'dire' financial troubles Dec 17th

The Public Interest Advocacy Centre, the voice behind some of the country’s most important consumer protections, is at risk of having to close its doors for good. And it says the CRTC, the regulator it has so often prodded over the past 42 years, is to blame for its financial troub.... More »

Sears Canada board members have earned more than $600K since retailer's demise — and are still being paid Aug 2nd

The law firm representing former employees will appear in court this month to aruge that Sears' Canada's board of directors is a financial drain and should be disbanded..... More »

A Win-Win Possibility for China-U.S. Trade + MORE Jul 1st

Bilateral investment treaty talks on July 9-10 could pay big dividends..... More »
 IPO

‘Yes’ and ‘No’ in tight race in Greece, poll shows + MORE Jul 3rd

Giorgos, a 77-year-old pensioner from Athens, sits outside a branch of the National Bank of Greece as he waits along with dozens of other pensioners, hoping to get their pensions in Athens, Greece June 29, 2015. Greece closed its banks and imposed capital controls on Sunday to check the growing stra.... More »

Questrade Review 2023: What matters to Canadian investors + MORE Jun 27th

For over 20 years, Questrade has provided Canadian investors with its attractive fees on a full range of assets—including stocks, mutual funds,  ETFs, initial public offerings (IPOs), bonds, and even gold and silver. If you’re shopping around for a discount brokerage, you’ve likely c.... More »
TORONTO – Patheon Inc. (TSX:PTI) has received a friendly going-private proposal that values the TSX-listed company at about US$1.4 billion, more than 50 per cent above its recent market price.
The offer of US$9.32 per share cash for minority shareholders is coming from a group backed by Patheon’s largest shareholder, U.S. private equity firm JLL Partners.
JLL and European life sciences company Royal DSM plan to combine Patheon into a new global contract drug manufacturer with 23 locations around the world and 8,300 employees.
The new company will be owned 51 per cent by JLL and 49 per cent by Royal DSM.
JLL Partners currently owns about 55.7 per cent of Patheon’s equity.
As a result, the takeover offer would cost about US$582 million cash to buy out shareholders other than JLL and its affiliates.
Patheon shares closed Monday at C$5.94 at the Toronto Stock Exchange, giving it a market value of C$837 million at the time.
The post Friendly takeover offer for Patheon values contract drug maker at US$1…

Continue Reading On canadianbusiness.com »

With traditional assets looking scary, investors are piling into fine art – and breaking sales records

Continue Reading On theglobeandmail.com »

Bay TodayBusy day for MPs studying federal budget, Canada-EU trade agreementMontreal GazetteOTTAWA – Members of Parliament will be busy today at committees dealing with the economy and trade. Citizenship and Immigration Minister Chris Alexander appears before a Commons committee hearing witnesses on Bill C-4, the Budget Implementation …Ottawa agenda for Monday: Parliament returns, economy, investment and healthWinnipeg Free Pressall 18 news articles »

Continue Reading On Montrealgazette.com »

5.5 year – 3.00%

– ratesupermarket.ca

This GIC rate is offered by Outlook Financial and was updated on 2013-10-30. Click on the link above to get more details or apply online.

Continue Reading On ratesupermarket.ca »

The virtual currency known as Bitcoin took a step away from the margins of the financial system Monday, as the U.S. Senate homeland security and governmental affairs committee set aside a good chunk of the afternoon for testimony on whether the …

Continue Reading On theglobeandmail.com »

Share

PinIt
Compare insurance quotes through Kanetix.ca - save time and money!